Morningstar Acciones

Straumann Holding AG STMN StarRatingValueLabel_1Mr. Lee Davidson, Head of Quantitative Research

Último Precio
133,10
Cambio del día
0,00|0,00%

a 19/04/2024
17:30:13 CEST | CHF  Minimum 15 Minutes Delay.

Bid/OffersRango del DíaVolumen90d Ave VolCapitalización
132,00 - 135,00131,80 - 134,40197.694210.04821,22Bil
Último Cierre52 Week RangeP/BeneficioDividendo %ISIN
133,1097,00 - 151,5087,270,63CH1175448666

Cotización Straumann Holding AG

Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
Cuentas Financieras
202120222023
More...
Cuenta de Resultados
Ingresos2.021,902.320,792.411,82
Operating Income537,00530,49410,97
Resultado Neto396,08434,79246,07
Beneficio Básico por Acción2,492,731,54
Num Medio Acciones diluidas en circulación160160160
Balance
Activo Corriente1.528,671.593,221.390,28
Activos no corrientes1.439,371.780,221.931,70
Total Activo 2.968,043.373,443.321,98
Pasivo corriente562,63972,10714,18
Total Pasivo---
Total Equity1.495,401.851,601.836,18
Flujo de Caja
Flujo de caja operativo560,30415,16503,95
Inversiones de Capital-120,97-195,43-189,43
Flujo de Caja Libre439,33219,72314,52

En millones, excepto "EPS básico". Currency is CHF.

Perfil de la compañía

Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company’s core products are dental implants, and it holds roughly one third of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Sector

Atención sanitaria

Industria

Instrumentos y Suministros Médicos

Estilo de acciones

Grande-Crecim

Fin Ejercicio Fiscal

diciembre

Empleados

11.109
Datos destacados
More...
Precio/Beneficio 12 m86,43
Precio/Valor contable11,56
Price/Sales TTM8,81
Crec Ingresos (media 3 a)19,15
Crec BPA (media 3 a)-
Margen operativo17,04
Margen neto10,20
ROE 12 m13,35
Deuda/Fondos propios0,21
Dividendos
AntLatest
Declared Date21/02/2327/02/24
Ex-Div11/04/2316/04/24
Paid13/04/2318/04/24
Amnt0,800,85
Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
© Copyright 2024 Morningstar, Inc. Reservados todos los derechos.

Términos de uso        Política Privacidad        Cookie Settings        Aviso Legal